[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Azithromycin is combined with Streptokinase.]
[J01EC01, sulfamethoxazole, The metabolism of Azithromycin can be decreased when combined with Sulfamethoxazole.]
[M04AB02, sulfinpyrazone, The metabolism of Azithromycin can be increased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Sulfisoxazole.]
[N05AL01, sulpiride, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Sulpiride.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Azithromycin.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Azithromycin.]
[R03CC03, terbutaline, The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Azithromycin.]
[B01AE07, dabigatran etexilate, The risk or severity of adverse effects can be increased when Azithromycin is combined with Dabigatran etexilate.]
[G03BA03, testosterone, The metabolism of Azithromycin can be increased when combined with Testosterone.]
[N07XX06, tetrabenazine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Tetracaine.]
[S03AA02, tetracycline, The metabolism of Azithromycin can be decreased when combined with Tetracycline.]
[N05AE05, lurasidone, The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Azithromycin.]
[N04BC07, apomorphine, The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Azithromycin.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Azithromycin.]
[L01XX41, eribulin, The risk or severity of QTc prolongation can be increased when Eribulin is combined with Azithromycin.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Azithromycin.]
[N05AC02, thioridazine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Azithromycin.]
[S01ED01, timolol, The risk or severity of QTc prolongation can be increased when Timolol is combined with Azithromycin.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Azithromycin.]
[S01BA05, triamcinolone, Azithromycin may decrease the excretion rate of Triamcinolone which could result in a higher serum level.]
[R03BA07, mometasone, The metabolism of Azithromycin can be increased when combined with Mometasone.]
[A03AA05, trimebutine, The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Azithromycin.]
[R06AD01, trimeprazine, The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Azithromycin.]
[N03AC02, trimethadione, The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Azithromycin.]
[N06AA06, trimipramine, The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Azithromycin.]
[R06AX07, triprolidine, The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Azithromycin.]
[J01FA08, troleandomycin, The metabolism of Azithromycin can be decreased when combined with Troleandomycin.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Azithromycin.]
[L01EX04, vandetanib, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Vandetanib.]
[A10BH05, linagliptin, The metabolism of Azithromycin can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Azithromycin can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The serum concentration of Telaprevir can be increased when it is combined with Azithromycin.]
[J05AG05, rilpivirine, The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Azithromycin.]
[B01AD04, urokinase, The risk or severity of adverse effects can be increased when Azithromycin is combined with Urokinase.]
[N03AX21, ezogabine, The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Azithromycin.]
[B01AF01, rivaroxaban, The risk or severity of adverse effects can be increased when Azithromycin is combined with Rivaroxaban.]
[R03AC18, indacaterol, The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Azithromycin.]
[B01AC24, ticagrelor, The risk or severity of adverse effects can be increased when Azithromycin is combined with Ticagrelor.]
[C08DA01, verapamil, The metabolism of Azithromycin can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Azithromycin can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Azithromycin.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Azithromycin.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Azithromycin.]
[A11HA03, vitamin E, The metabolism of Azithromycin can be increased when combined with Vitamin E.]
[B01AA03, warfarin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Warfarin.]
[N05AF05, zuclopenthixol, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Azithromycin can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Vemurafenib.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Azithromycin.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Azithromycin.]
[B01AE01, desirudin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Lepirudin.]
[R03DC01, zafirlukast, The metabolism of Azithromycin can be decreased when combined with Zafirlukast.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Azithromycin.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be decreased when combined with Azithromycin.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Azithromycin.]
[G04BD07, tolterodine, The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Azithromycin.]
[J02AC03, voriconazole, The metabolism of Azithromycin can be decreased when combined with Voriconazole.]
[S01FA01, atropine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Atropine.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Azithromycin.]
[R07AX02, ivacaftor, The metabolism of Azithromycin can be decreased when combined with Ivacaftor.]
[H02AB11, prednylidene, The serum concentration of Prednylidene can be increased when it is combined with Azithromycin.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Azithromycin.]
[G04BD12, mirabegron, The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Azithromycin.]
[V03AX03, cobicistat, The metabolism of Azithromycin can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Azithromycin can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Azithromycin can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Azithromycin.]
[B01AX01, defibrotide, The risk or severity of adverse effects can be increased when Azithromycin is combined with Defibrotide.]
[H02AA01, aldosterone, The serum concentration of Aldosterone can be increased when it is combined with Azithromycin.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Azithromycin.]
[N05CA04, barbital, The metabolism of Azithromycin can be increased when combined with Barbital.]
[C01AA01, acetyldigitoxin, The serum concentration of Acetyldigitoxin can be increased when it is combined with Azithromycin.]
[J05AE04, nelfinavir, The serum concentration of Azithromycin can be increased when it is combined with Nelfinavir.]
[N03AX22, perampanel, The metabolism of Azithromycin can be increased when combined with Perampanel.]
[H01CB05, pasireotide, The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Azithromycin.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Azithromycin.]
[B01AF02, apixaban, The risk or severity of adverse effects can be increased when Azithromycin is combined with Apixaban.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Azithromycin.]
[J04AK05, bedaquiline, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Bedaquiline.]
[C04AX11, bencyclane, The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Azithromycin.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Azithromycin can be increased when combined with Glycerol phenylbutyrate.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Azithromycin.]
[J01MA15, gemifloxacin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Moxifloxacin.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Benzocaine.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Azithromycin.]
[N04AC01, benztropine, The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Azithromycin.]
[L01EC02, dabrafenib, The serum concentration of Azithromycin can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Benzyl alcohol.]
[C08EA02, bepridil, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Bepridil.]
[N03AF04, eslicarbazepine, The metabolism of Azithromycin can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Azithromycin can be decreased when combined with Simeprevir.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Azithromycin.]
[A16AA07, metreleptin, The metabolism of Azithromycin can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Azithromycin can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Azithromycin can be increased when combined with Formestane.]
[S03BA03, betamethasone, The serum concentration of Betamethasone can be increased when it is combined with Azithromycin.]
[B01AE03, argatroban, The risk or severity of adverse effects can be increased when Azithromycin is combined with Argatroban.]
[L04AC11, siltuximab, The metabolism of Azithromycin can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Azithromycin.]
[B01AC26, vorapaxar, The risk or severity of adverse effects can be increased when Azithromycin is combined with Vorapaxar.]
[A03BA03, hyoscyamine, The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Azithromycin.]
[B01AA07, acenocoumarol, The risk or severity of adverse effects can be increased when Azithromycin is combined with Acenocoumarol.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Azithromycin.]
[R03AC19, olodaterol, The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Azithromycin.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Azithromycin.]
[A16AX10, eliglustat, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Azithromycin can be increased when combined with Oritavancin.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Azithromycin.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Azithromycin.]
[B01AA01, dicumarol, The risk or severity of adverse effects can be increased when Azithromycin is combined with Dicoumarol.]
[B01AF03, edoxaban, The risk or severity of adverse effects can be increased when Azithromycin is combined with Edoxaban.]
[N06AX11, mirtazapine, The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Azithromycin.]
[L04AC10, secukinumab, The metabolism of Azithromycin can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Azithromycin.]
[L01EX08, lenvatinib, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Lenvatinib.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Azithromycin.]
[N02BE01, acetaminophen, The metabolism of Azithromycin can be increased when combined with Acetaminophen.]
[B01AA11, tioclomarol, The risk or severity of adverse effects can be increased when Azithromycin is combined with Tioclomarol.]
[C01EB17, ivabradine, Ivabradine may increase the QTc-prolonging activities of Azithromycin.]
[J05AP06, asunaprevir, The metabolism of Azithromycin can be increased when combined with Asunaprevir.]
[B01AC25, cangrelor, The risk or severity of adverse effects can be increased when Azithromycin is combined with Cangrelor.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Azithromycin.]
[S01EC01, acetazolamide, The metabolism of Azithromycin can be decreased when combined with Acetazolamide.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Azithromycin.]
[J02AC05, isavuconazole, The metabolism of Azithromycin can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Azithromycin.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be decreased when combined with Azithromycin.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Azithromycin.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Azithromycin.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Azithromycin.]
[G04CA01, alfuzosin, The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Azithromycin.]
[M04AB05, lesinurad, The metabolism of Azithromycin can be increased when combined with Lesinurad.]
[N05CA05, aprobarbital, The metabolism of Azithromycin can be increased when combined with Aprobarbital.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Azithromycin.]
[N04BC01, bromocriptine, The serum concentration of Bromocriptine can be increased when it is combined with Azithromycin.]
[R06AB01, brompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Azithromycin.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Azithromycin.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Bupivacaine.]
[C07AA19, bupranolol, The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Azithromycin.]
[N07BC01, buprenorphine, The metabolism of Azithromycin can be decreased when combined with Buprenorphine.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Buserelin is combined with Azithromycin.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Azithromycin.]
[L01XX27, arsenic trioxide, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Arsenic trioxide.]
[P01BE02, artemether, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Artemether.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Sparfloxacin.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Azithromycin.]
[L01XK03, rucaparib, The metabolism of Azithromycin can be decreased when combined with Rucaparib.]
[S01AA13, fusidic acid, The metabolism of Azithromycin can be decreased when combined with Fusidic acid.]
[J01MB04, pipemidic acid, The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Azithromycin can be decreased when combined with Ribociclib.]
[N07XX16, deutetrabenazine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Azithromycin.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Oxybuprocaine.]
[D05AX03, calcitriol, The metabolism of Azithromycin can be increased when combined with Calcitriol.]
[J05AE09, tipranavir, The metabolism of Azithromycin can be decreased when combined with Tipranavir.]
[L04AB02, infliximab, The metabolism of Azithromycin can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Azithromycin can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Azithromycin.]
[L04AC14, sarilumab, The metabolism of Azithromycin can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Azithromycin.]
[B01AF04, betrixaban, The risk or severity of adverse effects can be increased when Azithromycin is combined with Betrixaban.]
[D01AC10, bifonazole, The metabolism of Azithromycin can be decreased when combined with Bifonazole.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Azithromycin.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Azithromycin.]
[L01XH01, vorinostat, The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Azithromycin.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Azithromycin.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Azithromycin.]
[J05AG03, efavirenz, The metabolism of Azithromycin can be decreased when combined with Efavirenz.]
[R03BA02, budesonide, The serum concentration of Budesonide can be increased when it is combined with Azithromycin.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Azithromycin.]
[J05AX18, letermovir, The metabolism of Azithromycin can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Butriptyline.]
[C01AA02, acetyldigoxins, The serum concentration of Acetyldigoxin can be increased when it is combined with Azithromycin.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Capsaicin.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Azithromycin.]
[V04CD06, macimorelin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Macimorelin.]
[L02BB05, apalutamide, The metabolism of Azithromycin can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Azithromycin can be increased when combined with Carbamazepine.]
[R06AA08, carbinoxamine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Carbinoxamine.]
[B02BX09, fostamatinib, The metabolism of Azithromycin can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The metabolism of Azithromycin can be decreased when combined with Cannabidiol.]
[L01EC03, encorafenib, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Encorafenib.]
[C07AB08, celiprolol, The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Azithromycin.]
[L01XX62, ivosidenib, The metabolism of Azithromycin can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Azithromycin can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Azithromycin can be increased when combined with Tecovirimat.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Azithromycin.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Azithromycin.]
[S01GX12, cetirizine, The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Azithromycin.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Chloroprocaine.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Inotersen is combined with Azithromycin.]
[L01ED05, lorlatinib, The metabolism of Azithromycin can be increased when combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Azithromycin can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Gilteritinib.]
[L01XJ03, glasdegib, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Glasdegib.]
[N07XX05, amifampridine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Amifampridine.]
[C01BG07, cifenline, The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Azithromycin.]
[B01AC23, cilostazol, The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Azithromycin.]
[P02BX04, triclabendazole, The metabolism of Azithromycin can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Azithromycin can be increased when combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Azithromycin.]
[J01FA09, clarithromycin, The metabolism of Azithromycin can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Azithromycin.]
[N05BA09, clobazam, The metabolism of Azithromycin can be increased when combined with Clobazam.]
[H02AB14, cloprednol, The serum concentration of Cloprednol can be increased when it is combined with Azithromycin.]
[L04AB01, etanercept, The metabolism of Azithromycin can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The serum concentration of Cortivazol can be increased when it is combined with Azithromycin.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Azithromycin.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Azithromycin.]
[C03BX03, cicletanine, The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Azithromycin.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Azithromycin can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Azithromycin.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Azithromycin.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be decreased when combined with Azithromycin.]
[J01DB09, cephradine, The metabolism of Azithromycin can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be increased when it is combined with Azithromycin.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Azithromycin.]
[N03AX25, cenobamate, The serum concentration of Azithromycin can be decreased when it is combined with Cenobamate.]
[R06AB06, dexbrompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Azithromycin.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Dexchlorpheniramine.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Azithromycin.]
[J05AB16, remdesivir, The metabolism of Azithromycin can be decreased when combined with Remdesivir.]
[S01AE06, gatifloxacin, The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Azithromycin.]
[H02CA02, osilodrostat, The metabolism of Azithromycin can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Azithromycin can be decreased when combined with Amprenavir.]
[M01AH02, rofecoxib, The metabolism of Azithromycin can be increased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Azithromycin can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Azithromycin can be increased when combined with Clevidipine.]
[C01BD07, dronedarone, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Dronedarone.]
[J01FA13, dirithromycin, The metabolism of Azithromycin can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Azithromycin can be decreased when combined with Chloramphenicol.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Azithromycin.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Azithromycin.]
[D07XB03, fluprednidene, The metabolism of Azithromycin can be increased when combined with Fluprednidene.]
[B01AE02, lepirudin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Lepirudin.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Dyclonine.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Azithromycin.]
[J05AX29, fostemsavir, The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Azithromycin.]
[L04AC19, satralizumab, The serum concentration of Azithromycin can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Chloroquine.]
[L01EX23, pralsetinib, The metabolism of Azithromycin can be increased when combined with Pralsetinib.]
[R06AB04, chlorpheniramine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Chlorpromazine.]
[N05AF03, chlorprothixene, The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Azithromycin.]
[B06AC06, berotralstat, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Azithromycin can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The risk or severity of QTc prolongation can be increased when Relugolix is combined with Azithromycin.]
[P03AX07, abametapir, The serum concentration of Azithromycin can be increased when it is combined with Abametapir.]
[N03AX10, felbamate, The metabolism of Azithromycin can be increased when combined with Felbamate.]
[J01MB07, flumequine, The risk or severity of QTc prolongation can be increased when Flumequine is combined with Azithromycin.]
[R03BA03, flunisolide, The serum concentration of Flunisolide can be increased when it is combined with Azithromycin.]
[S02BA08, fluocinolone acetonide, The metabolism of Azithromycin can be increased when combined with Fluocinolone acetonide.]
[R03CC15, formoterol, The risk or severity of QTc prolongation can be increased when Formoterol is combined with Azithromycin.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Azithromycin.]
[A02BA01, cimetidine, The metabolism of Azithromycin can be decreased when combined with Cimetidine.]
[N07CA02, cinnarizine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Cinnarizine.]
[J01MB06, cinoxacin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Azithromycin can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Azithromycin.]
[S03AA07, ciprofloxacin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Ciprofloxacin.]
[N06AB04, citalopram, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Citalopram.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Azithromycin is combined with Fexinidazole.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Mobocertinib.]
[L04AA59, avacopan, The metabolism of Azithromycin can be decreased when combined with Avacopan.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Clemastine.]
[N06AX25, St. John's wort extract, The metabolism of Azithromycin can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Azithromycin can be decreased when combined with Asciminib.]
[J04BA01, clofazimine, The metabolism of Azithromycin can be decreased when combined with Clofazimine.]
[B01AD11, tenecteplase, The risk or severity of adverse effects can be increased when Azithromycin is combined with Tenecteplase.]
[C10AB01, clofibrate, The metabolism of Azithromycin can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Azithromycin can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The metabolism of Azithromycin can be decreased when combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Azithromycin.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Azithromycin.]
[C01EB24, mavacamten, The serum concentration of Azithromycin can be decreased when it is combined with Mavacamten.]
[A04AA01, ondansetron, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Granisetron.]
[N05AH02, clozapine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Clozapine.]
[H01AC08, somatrogon, The metabolism of Azithromycin can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Azithromycin can be increased when combined with Bimekizumab.]
[N01AB07, desflurane, The risk or severity of QTc prolongation can be increased when Desflurane is combined with Azithromycin.]
[J01FA15, telithromycin, The metabolism of Azithromycin can be decreased when combined with Telithromycin.]
[R06AX27, desloratadine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Desloratadine.]
[C01AA06, lanatoside C, The serum concentration of Lanatoside C can be increased when it is combined with Azithromycin.]
[J02AC02, itraconazole, The metabolism of Azithromycin can be decreased when combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Bemiparin.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Emedastine.]
[N05BA10, ketazolam, The metabolism of Azithromycin can be decreased when combined with Ketazolam.]
[L01EA01, imatinib, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Azithromycin can be decreased when combined with Posaconazole.]
[C08CA09, lacidipine, The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Azithromycin.]
[N03AX09, lamotrigine, The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Azithromycin.]
[S01GX02, levocabastine, The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Azithromycin.]
[S01BA03, cortisone, The serum concentration of Cortisone can be increased when it is combined with Azithromycin.]
[N07BC04, lofexidine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Lofexidine.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Lomefloxacin.]
[C08CA11, manidipine, The metabolism of Azithromycin can be decreased when combined with Manidipine.]
[H02AB15, meprednisone, The serum concentration of Meprednisone can be increased when it is combined with Azithromycin.]
[R06AD07, mequitazine, The metabolism of Azithromycin can be decreased when combined with Mequitazine.]
[C01EB10, adenosine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Adenosine.]
[R06AE03, cyclizine, The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Azithromycin.]
[N05AD03, metylperon, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Melperone.]
[J01FA03, midecamycin, The metabolism of Azithromycin can be decreased when combined with Midecamycin.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Azithromycin.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Azithromycin.]
[N06BA07, modafinil, The metabolism of Azithromycin can be increased when combined with Modafinil.]
[R06AX02, cyproheptadine, The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Azithromycin.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Azithromycin.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Azithromycin.]
[C03XA02, conivaptan, The metabolism of Azithromycin can be decreased when combined with Conivaptan.]
[G04BE09, vardenafil, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Azithromycin.]
[M01AH05, etoricoxib, The metabolism of Azithromycin can be decreased when combined with Etoricoxib.]
[G03XA01, danazol, The metabolism of Azithromycin can be decreased when combined with Danazol.]
[L01DB02, daunorubicin, The metabolism of Azithromycin can be decreased when combined with Daunorubicin.]
[N06AX06, nefazodone, The metabolism of Azithromycin can be decreased when combined with Nefazodone.]
[M03AC11, cisatracurium, Azithromycin may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, The risk or severity of adverse effects can be increased when Azithromycin is combined with Fondaparinux.]
[N06AB10, escitalopram, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Escitalopram.]
[G04BD08, solifenacin, The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Azithromycin.]
[N06AA01, desipramine, The metabolism of Azithromycin can be decreased when combined with Desipramine.]
[C01AA07, deslanoside, The serum concentration of Deslanoside can be increased when it is combined with Azithromycin.]
[L01XA03, oxaliplatin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Oxaliplatin.]
[N03AF02, oxcarbazepine, The metabolism of Azithromycin can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The serum concentration of Dexamethasone can be increased when it is combined with Azithromycin.]
[G04BD04, oxybutynin, The metabolism of Azithromycin can be decreased when combined with Oxybutynin.]
[L04AB04, adalimumab, The metabolism of Azithromycin can be increased when combined with Adalimumab.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Cinchocaine.]
[J01CF01, dicloxacillin, The metabolism of Azithromycin can be increased when combined with Dicloxacillin.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Azithromycin.]
[A03AX04, pinaverium, The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Azithromycin.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Azithromycin.]
[L01EB02, erlotinib, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Erlotinib.]
[L02AA01, diethylstilbestrol, The metabolism of Azithromycin can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Azithromycin can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Azithromycin can be increased when combined with Difluocortolone.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Azithromycin.]
[C01AA05, digoxin, The serum concentration of Digoxin can be increased when it is combined with Azithromycin.]
[C04AE04, dihydroergocristine, The serum concentration of Dihydroergocristine can be increased when it is combined with Azithromycin.]
[N02CA01, dihydroergotamine, The serum concentration of Dihydroergotamine can be increased when it is combined with Azithromycin.]
[J05AE08, atazanavir, The metabolism of Azithromycin can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Azithromycin.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Pramocaine.]
[C08DB01, diltiazem, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Dimenhydrinate.]
[M02AX03, dimethyl sulfoxide, The metabolism of Azithromycin can be decreased when combined with Dimethyl sulfoxide.]
[C05CA03, diosmin, The metabolism of Azithromycin can be decreased when combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Diphenhydramine.]
[B01AC07, dipyridamole, The risk or severity of adverse effects can be increased when Azithromycin is combined with Dipyridamole.]
[B01AD10, drotrecogin alfa, The risk or severity of adverse effects can be increased when Azithromycin is combined with Drotrecogin alfa.]
[A03FA02, cisapride, The serum concentration of Cisapride can be increased when it is combined with Azithromycin.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Azithromycin.]
[C01BA03, disopyramide, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Disopyramide.]
[P03AA04, disulfiram, The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Azithromycin.]
[S02AA12, rifamycin SV, The metabolism of Azithromycin can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Azithromycin can be increased when combined with Rifapentine.]
[N05AX08, risperidone, The risk or severity of QTc prolongation can be increased when Risperidone is combined with Azithromycin.]
[R06AE09, levocetirizine, The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Azithromycin.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Ropivacaine.]
[J01MB01, rosoxacin, The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Azithromycin.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Azithromycin.]
[A04AD12, aprepitant, The metabolism of Azithromycin can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Azithromycin.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Azithromycin.]
[J05AE07, fosamprenavir, The metabolism of Azithromycin can be decreased when combined with Fosamprenavir.]
[C01EB18, ranolazine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Ranolazine.]
[R03AC12, salmeterol, The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Azithromycin.]
[A03FA03, domperidone, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Domperidone.]
[N06AA16, dothiepin, The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Azithromycin.]
[N06AA12, doxepin, The risk or severity of QTc prolongation can be increased when Doxepin is combined with Azithromycin.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Azithromycin.]
[R06AA09, doxylamine, The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Azithromycin.]
[N01AB08, sevoflurane, The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Azithromycin.]
[N05AD08, droperidol, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Droperidol.]
[N05AL02, sultopride, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Sultopride.]
[C07AB13, talinolol, The risk or severity of QTc prolongation can be increased when Talinolol is combined with Azithromycin.]
[H01AA01, corticotropin, The serum concentration of Corticotropin can be increased when it is combined with Azithromycin.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Temafloxacin.]
[D01BA02, terbinafine, The metabolism of Azithromycin can be increased when combined with Terbinafine.]
[G04BD05, terodiline, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Terodiline.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Azithromycin.]
[N06BA09, atomoxetine, The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Azithromycin.]
[N03AX11, topiramate, The metabolism of Azithromycin can be increased when combined with Topiramate.]
[L02BA02, toremifene, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Toremifene.]
[B01AC18, triflusal, The risk or severity of adverse effects can be increased when Azithromycin is combined with Triflusal.]
[H02CA01, trilostane, The serum concentration of Trilostane can be increased when it is combined with Azithromycin.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Azithromycin.]
[C05CA04, troxerutin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Troxerutin.]
[J01MA04, enoxacin, The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Azithromycin.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Azithromycin.]
[S01GX10, epinastine, The risk or severity of QTc prolongation can be increased when Epinastine is combined with Azithromycin.]
[C08CA12, mepirodipine, The metabolism of Azithromycin can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Azithromycin can be decreased when combined with Epinephrine.]
[N03AX15, zonisamide, The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Azithromycin.]
[B01AD03, anistreplase, The risk or severity of adverse effects can be increased when Azithromycin is combined with Anistreplase.]
[C01BG01, moricizine, The risk or severity of QTc prolongation can be increased when Moricizine is combined with Azithromycin.]
[G02AB03, ergonovine, The serum concentration of Ergometrine can be increased when it is combined with Azithromycin.]
[C04AE01, ergoloid mesylates, USP, The serum concentration of Ergoloid mesylate can be increased when it is combined with Azithromycin.]
[N02CA02, ergotamine, The metabolism of Azithromycin can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Azithromycin.]
[J04AK02, ethambutol, The metabolism of Azithromycin can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Azithromycin can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Azithromycin can be increased when combined with Fluticasone.]
[C01BD05, ibutilide, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Ibutilide.]
[N03AD01, ethosuximide, The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Azithromycin.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Etidocaine.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Azithromycin.]
[C01BA05, ajmaline, The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Azithromycin.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Azithromycin.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Azithromycin.]
[R06AX11, astemizole, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Astemizole.]
[R06AX12, terfenadine, The serum concentration of Terfenadine can be increased when it is combined with Azithromycin.]
[N06AB08, fluvoxamine, The metabolism of Azithromycin can be decreased when combined with Fluvoxamine.]
[C01BC08, encainide, The risk or severity of QTc prolongation can be increased when Encainide is combined with Azithromycin.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Azithromycin.]
[B05AA05, dextran, The risk or severity of adverse effects can be increased when Azithromycin is combined with Dextran.]
[A02BA03, famotidine, The risk or severity of QTc prolongation can be increased when Famotidine is combined with Azithromycin.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Azithromycin.]
[C08CA02, felodipine, The risk or severity of QTc prolongation can be increased when Felodipine is combined with Azithromycin.]
[C08EA01, fendiline, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Fendiline.]
[R03CC02, albuterol, The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Azithromycin.]
[B01AD05, plasmin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Fibrinolysin.]
[C01BC04, flecainide, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Flecainide.]
[J01CF05, floxacillin, The metabolism of Azithromycin can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The metabolism of Azithromycin can be decreased when combined with Fluconazole.]
[H02AA02, fludrocortisone, The serum concentration of Fludrocortisone can be increased when it is combined with Azithromycin.]
[D07AC08, fluocinonide, The metabolism of Azithromycin can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Azithromycin can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Azithromycin can be increased when combined with Ethanol.]
[L01BC02, fluorouracil, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Fluorouracil.]
[N06AB03, fluoxetine, The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Azithromycin.]
[N05AF01, flupenthixol, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Flupentixol.]
[N05AG01, fluspirilene, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Fluspirilene.]
[J05AE10, darunavir, The metabolism of Azithromycin can be decreased when combined with Darunavir.]
[N05AL05, amisulpride, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Amisulpride.]
[N06DA04, galantamine, The risk or severity of QTc prolongation can be increased when Galantamine is combined with Azithromycin.]
[C08DA02, gallopamil, The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Azithromycin.]
[N03AA04, barbexaclone, The metabolism of Azithromycin can be increased when combined with Barbexaclone.]
[J01XA03, telavancin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Telavancin.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Degarelix is combined with Azithromycin.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Azithromycin.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be increased when it is combined with Azithromycin.]
[J05AG04, etravirine, The metabolism of Azithromycin can be increased when combined with Etravirine.]
[N03AD03, methsuximide, The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Azithromycin.]
[L01EH01, lapatinib, The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Azithromycin.]
[A10BB01, glyburide, The metabolism of Azithromycin can be decreased when combined with Glyburide.]
[C01BD04, dofetilide, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Dofetilide.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Azithromycin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Azithromycin.]
[C07AB09, esmolol, The risk or severity of QTc prolongation can be increased when Esmolol is combined with Azithromycin.]
[B01AA12, fluindione, The risk or severity of adverse effects can be increased when Azithromycin is combined with Fluindione.]
[D01BA01, griseofulvin, The metabolism of Azithromycin can be increased when combined with Griseofulvin.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Goserelin is combined with Azithromycin.]
[P01BX01, halofantrine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Haloperidol.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Histrelin is combined with Azithromycin.]
[N05AH04, quetiapine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Quetiapine.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Azithromycin.]
[C09CA01, losartan, The metabolism of Azithromycin can be decreased when combined with Losartan.]
[S01XA14, heparin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Heparin.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Azithromycin.]
[C08CA10, nilvadipine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Nilvadipine.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Oxatomide.]
[C02DB02, hydralazine, The metabolism of Azithromycin can be decreased when combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Azithromycin.]
[S02BA01, hydrocortisone, The serum concentration of Hydrocortisone can be increased when it is combined with Azithromycin.]
[P01BA02, hydroxychloroquine, The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Azithromycin.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Azithromycin can be increased when combined with Rifabutin.]
[B05CB02, sodium citrate, The risk or severity of adverse effects can be increased when Azithromycin is combined with Sodium citrate.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Azithromycin.]
[N06AA02, imipramine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Azithromycin.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Terlipressin.]
[M03BX02, tizanidine, The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Azithromycin.]
[C03BA11, indapamide, The risk or severity of QTc prolongation can be increased when Indapamide is combined with Azithromycin.]
[N06AX17, milnacipran, The metabolism of Azithromycin can be decreased when combined with Milnacipran.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Articaine.]
[R06AE01, buclizine, The risk or severity of QTc prolongation can be increased when Buclizine is combined with Azithromycin.]
[C10AA06, cerivastatin, The metabolism of Azithromycin can be increased when combined with Cerivastatin.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Anagrelide.]
[N01AB06, isoflurane, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Azithromycin.]
[J04AC01, isoniazid, The metabolism of Azithromycin can be decreased when combined with Isoniazid.]
[P02CF01, ivermectin, The serum concentration of Ivermectin can be increased when it is combined with Azithromycin.]
[B01AE06, bivalirudin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Bivalirudin.]
[L04AC07, tocilizumab, The metabolism of Azithromycin can be increased when combined with Tocilizumab.]
[B01AC22, prasugrel, The risk or severity of adverse effects can be increased when Azithromycin is combined with Prasugrel.]
[H02CA04, levoketoconazole, The metabolism of Azithromycin can be decreased when combined with Levoketoconazole.]
[J02AB02, ketoconazole, The metabolism of Azithromycin can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Azithromycin.]
[V03AC03, deferasirox, The metabolism of Azithromycin can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Azithromycin can be increased when combined with Abatacept.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Mizolastine.]
[J01MB02, nalidixic acid, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Nalidixic acid.]
[N04BB01, amantadine, The risk or severity of QTc prolongation can be increased when Amantadine is combined with Azithromycin.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Azithromycin.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Azithromycin.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Lidocaine.]
[C08EX01, lidoflazine, The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Azithromycin.]
[N06BA13, armodafinil, The metabolism of Azithromycin can be increased when combined with Armodafinil.]
[N02CA07, lisuride, The serum concentration of Lisuride can be increased when it is combined with Azithromycin.]
[A07DA03, loperamide, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Loperamide.]
[C10AA02, lovastatin, The metabolism of Azithromycin can be decreased when combined with Lovastatin.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Azithromycin.]
[L01EA03, nilotinib, The metabolism of Azithromycin can be decreased when combined with Nilotinib.]
[N06AA21, maprotiline, The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Azithromycin.]
[C01AA08, medigoxin, The serum concentration of Metildigoxin can be increased when it is combined with Azithromycin.]
[P01BC02, mefloquine, The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Azithromycin.]
[B01AB06, nadroparin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Dalteparin.]
[N02AB02, meperidine, The metabolism of Meperidine can be decreased when combined with Azithromycin.]
[N03AA01, mephobarbital, The metabolism of Azithromycin can be increased when combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Mepivacaine.]
[L02BG01, aminoglutethimide, The metabolism of Azithromycin can be increased when combined with Aminoglutethimide.]
[N05AC03, mesoridazine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Mesoridazine.]
[N05AX13, paliperidone, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Paliperidone.]
[A04AA04, dolasetron, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Dolasetron.]
[H01CB03, lanreotide, The metabolism of Azithromycin can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Methadone.]
[G02CB05, metergoline, The serum concentration of Metergoline can be increased when it is combined with Azithromycin.]
[H03BB02, methimazole, The metabolism of Azithromycin can be decreased when combined with Methimazole.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Azithromycin.]
[N05AA02, methotrimeprazine, The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Azithromycin.]
[V04CG05, methylene blue, The metabolism of Azithromycin can be decreased when combined with Methylene blue.]
[G02AB01, methylergonovine, The serum concentration of Methylergometrine can be increased when it is combined with Azithromycin.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Azithromycin.]
[H02AB04, methylprednisolone, The serum concentration of Methylprednisolone can be increased when it is combined with Azithromycin.]
[N03AF03, rufinamide, The metabolism of Azithromycin can be increased when combined with Rufinamide.]
[N02CA04, methysergide, The serum concentration of Methysergide can be increased when it is combined with Azithromycin.]
[A03FA01, metoclopramide, The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Azithromycin.]
[P01AB01, metronidazole, The metabolism of Azithromycin can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Azithromycin can be increased when combined with Metyrapone.]
[S02AA13, miconazole, The metabolism of Azithromycin can be decreased when combined with Miconazole.]
[B01AB07, parnaparin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Parnaparin.]
[N05CD08, midazolam, The metabolism of Azithromycin can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Mifepristone.]
[B01AB10, tinzaparin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Tinzaparin.]
[J01FA11, miocamycin, The metabolism of Azithromycin can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Azithromycin can be increased when combined with Mitotane.]
[L03AC01, aldesleukin, The metabolism of Azithromycin can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Azithromycin can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Amitriptyline.]
[L04AB05, certolizumab pegol, The metabolism of Azithromycin can be increased when combined with Certolizumab pegol.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Azithromycin.]
[N05CA02, amobarbital, The metabolism of Azithromycin can be increased when combined with Amobarbital.]
[P01BA06, amodiaquine, The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Azithromycin.]
[G03XC01, raloxifene, The metabolism of Azithromycin can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Azithromycin.]
[N03AB05, fosphenytoin, The metabolism of Azithromycin can be increased when combined with Fosphenytoin.]
[J01CF06, nafcillin, The metabolism of Azithromycin can be increased when combined with Nafcillin.]
[V03AB15, naloxone, The metabolism of Azithromycin can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Azithromycin can be increased when combined with Anakinra.]
[A10BG01, troglitazone, The metabolism of Azithromycin can be increased when combined with Troglitazone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Azithromycin.]
[C01CX08, levosimendan, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Levosimendan.]
[N05AX14, iloperidone, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Iloperidone.]
[N06AX23, desvenlafaxine, The metabolism of Azithromycin can be decreased when combined with Desvenlafaxine.]
[C10AD02, niacin, The metabolism of Azithromycin can be decreased when combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Azithromycin can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The serum concentration of Nicergoline can be increased when it is combined with Azithromycin.]
[C08CA05, nifedipine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Nifedipine.]
[C08CA06, nimodipine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Nimodipine.]
[C08CA08, nitrendipine, The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Azithromycin.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Azithromycin.]
[S01AE02, norfloxacin, The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Azithromycin.]
[C02KX01, bosentan, The metabolism of Azithromycin can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Azithromycin.]
[R05DA07, noscapine, The metabolism of Azithromycin can be decreased when combined with Noscapine.]
[B01AB08, reviparin, The risk or severity of adverse effects can be increased when Azithromycin is combined with Reviparin.]
[H01CB02, octreotide, The metabolism of Azithromycin can be decreased when combined with Octreotide.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Ofloxacin.]
[J01FA05, oleandomycin, The metabolism of Azithromycin can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Azithromycin can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Azithromycin can be increased when combined with Omeprazole.]
[B01AD07, reteplase, The risk or severity of adverse effects can be increased when Azithromycin is combined with Reteplase.]
[B01AD09, ancrod, The risk or severity of adverse effects can be increased when Azithromycin is combined with Ancrod.]
[C01AC01, ouabain, The serum concentration of Ouabain can be increased when it is combined with Azithromycin.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Azithromycin.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Azithromycin.]
[N05AH05, asenapine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Asenapine.]
[B01AB09, danaparoid, The risk or severity of adverse effects can be increased when Azithromycin is combined with Danaparoid.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Papaverine.]
[H02AB05, paramethasone, The serum concentration of Paramethasone can be increased when it is combined with Azithromycin.]
[J01MA03, pefloxacin, The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Azithromycin.]
[N05AG03, penfluridol, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Penfluridol.]
[N05CA01, pentobarbital, The metabolism of Azithromycin can be increased when combined with Pentobarbital.]
[N04BC02, pergolide, The serum concentration of Pergolide can be increased when it is combined with Azithromycin.]
[C08EX02, perhexiline, The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Azithromycin.]
[B01AA02, phenindione, The risk or severity of adverse effects can be increased when Azithromycin is combined with Phenindione.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Azithromycin.]
[N03AA02, phenobarbital, The metabolism of Azithromycin can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The risk or severity of adverse effects can be increased when Azithromycin is combined with Phenprocoumon.]
[M02AA01, phenylbutazone, The metabolism of Azithromycin can be increased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Azithromycin can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Azithromycin can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Levofloxacin.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Azithromycin.]
[C08CX01, mibefradil, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Mibefradil.]
[N05AG02, pimozide, The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Azithromycin is combined with Pimozide.]
[C10AA05, atorvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Azithromycin is combined with Atorvastatin.]
[J05AE01, saquinavir, The metabolism of Azithromycin can be decreased when combined with Saquinavir.]
[J01MA11, grepafloxacin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Grepafloxacin.]
[J05AG02, delavirdine, The metabolism of Azithromycin can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Azithromycin can be decreased when combined with Irbesartan.]
[B01AC13, abciximab, The risk or severity of adverse effects can be increased when Azithromycin is combined with Abciximab.]
[S01XA13, alteplase, The risk or severity of adverse effects can be increased when Azithromycin is combined with Alteplase.]
[L04AC08, canakinumab, The metabolism of Azithromycin can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The serum concentration of Azithromycin can be increased when it is combined with Ritonavir.]
[C01BA08, prajmaline, The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Azithromycin.]
[S03BA02, prednisolone, The serum concentration of Prednisolone can be increased when it is combined with Azithromycin.]
[H02AB07, prednisone, The serum concentration of Prednisone can be increased when it is combined with Azithromycin.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Antazoline.]
[C01DX02, prenylamine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Prenylamine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Prilocaine.]
[P01BA03, primaquine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Primaquine.]
[N03AA03, primidone, The metabolism of Azithromycin can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Azithromycin can be increased when combined with Probenecid.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Probucol.]
[C01BA02, procainamide, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Procainamide.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Procaine.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Azithromycin.]
[N05AB04, prochlorperazine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Prochlorperazine.]
[N05AA03, promazine, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Promazine.]
[R06AD02, promethazine, The risk or severity of QTc prolongation can be increased when Promethazine is combined with Azithromycin.]
[C01BC03, propafenone, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Propafenone.]
[L01XH02, romidepsin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Romidepsin.]
[N01AX10, propofol, The risk or severity of QTc prolongation can be increased when Propofol is combined with Azithromycin.]
[N02AC04, propoxyphene, The metabolism of Azithromycin can be decreased when combined with Dextropropoxyphene.]
[C01AB01, proscillaridin, The serum concentration of Proscillaridin can be increased when it is combined with Azithromycin.]
[B01AC09, epoprostenol, The risk or severity of adverse effects can be increased when Azithromycin is combined with Epoprostenol.]
[N06AA11, protriptyline, The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Azithromycin.]
[N05AX12, aripiprazole, The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Azithromycin.]
[R06AC01, pyrilamine, The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Azithromycin.]
[C01BA01, quinidine, The serum concentration of Quinidine can be increased when it is combined with Azithromycin.]
[P01BC01, quinine, The serum concentration of Quinine can be increased when it is combined with Azithromycin.]
[J04AB02, rifampin, The metabolism of Azithromycin can be increased when combined with Rifampicin.]
[J01FA06, roxithromycin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Roxithromycin.]
[N05CA06, secobarbital, The metabolism of Azithromycin can be increased when combined with Secobarbital.]
[H01CB01, somatostatin, The metabolism of Azithromycin can be decreased when combined with Somatostatin.]
[C07AA07, sotalol, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Sotalol.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Azithromycin.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Azithromycin.]
[N03AG01, valproic acid, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Azithromycin can be increased when combined with Hydrocortisone butyrate.]
[N05AL01, sulpiride, QT prolonging agents - QT prolonging agents]
[N05AC02, thioridazine, QT prolonging agents - QT prolonging agents]
[L01EX04, vandetanib, QT prolonging agents - QT prolonging agents]
[N06DA02, donepezil, QT prolonging agents - QT prolonging agents]
[S01AE07, moxifloxacin, QT prolonging agents - QT prolonging agents]
[C08EA02, bepridil, QT prolonging agents - QT prolonging agents]
[L01XX27, arsenic trioxide, QT prolonging agents - QT prolonging agents]
[J01MA09, sparfloxacin, QT prolonging agents - QT prolonging agents]
[B01AC23, cilostazol, QT prolonging agents - QT prolonging agents]
[J01FA09, clarithromycin, QT prolonging agents - QT prolonging agents]
[S01AE06, gatifloxacin, QT prolonging agents - QT prolonging agents]
[C01BD07, dronedarone, QT prolonging agents - QT prolonging agents]
[L01DB04, aclarubicin, QT prolonging agents - QT prolonging agents]
[P01BA01, chloroquine, QT prolonging agents - QT prolonging agents]
[N05AA01, chlorpromazine, QT prolonging agents - QT prolonging agents]
[N05AF03, chlorprothixene, QT prolonging agents - QT prolonging agents]
[S03AA07, ciprofloxacin, QT prolonging agents - QT prolonging agents]
[N06AB04, citalopram, QT prolonging agents - QT prolonging agents]
[L01EB10, mobocertinib, QT prolonging agents - QT prolonging agents]
[A04AA01, ondansetron, QT prolonging agents - QT prolonging agents]
[S02DA02, cocaine, QT prolonging agents - QT prolonging agents]
[C01BA13, hydroquinidine, QT prolonging agents - QT prolonging agents]
[P01CB01, meglumine antimoniate, QT prolonging agents - QT prolonging agents]
[L01XA03, oxaliplatin, QT prolonging agents - QT prolonging agents]
[A03FA02, cisapride, QT prolonging agents - QT prolonging agents]
[C01BA03, disopyramide, QT prolonging agents - QT prolonging agents]
[A03FA03, domperidone, QT prolonging agents - QT prolonging agents]
[N01AB08, sevoflurane, QT prolonging agents - QT prolonging agents]
[N05AD08, droperidol, QT prolonging agents - QT prolonging agents]
[N05AL02, sultopride, QT prolonging agents - QT prolonging agents]
[G04BD05, terodiline, QT prolonging agents - QT prolonging agents]
[S01AA17, erythromycin, QT prolonging agents - QT prolonging agents]
[C01BD05, ibutilide, QT prolonging agents - QT prolonging agents]
[N05AE03, sertindole, QT prolonging agents - QT prolonging agents]
[R06AX11, astemizole, QT prolonging agents - QT prolonging agents]
[R06AX12, terfenadine, QT prolonging agents - QT prolonging agents]
[C01BC04, flecainide, QT prolonging agents - QT prolonging agents]
[J02AC01, fluconazole, QT prolonging agents - QT prolonging agents]
[C01BD04, dofetilide, QT prolonging agents - QT prolonging agents]
[P01BX01, halofantrine, QT prolonging agents - QT prolonging agents]
[N05AD01, haloperidol, QT prolonging agents - QT prolonging agents]
[P01BA02, hydroxychloroquine, QT prolonging agents - QT prolonging agents]
[H01BA04, terlipressin, QT prolonging agents - QT prolonging agents]
[L01XX35, anagrelide, QT prolonging agents - QT prolonging agents]
[N05AC03, mesoridazine, QT prolonging agents - QT prolonging agents]
[N07BC02, methadone, QT prolonging agents - QT prolonging agents]
[N05AA02, methotrimeprazine, QT prolonging agents - QT prolonging agents]
[C01BD01, amiodarone, QT prolonging agents - QT prolonging agents]
[S01AE05, levofloxacin, QT prolonging agents - QT prolonging agents]
[N05AG02, pimozide, QT prolonging agents - QT prolonging agents]
[J01MA11, grepafloxacin, QT prolonging agents - QT prolonging agents]
[C10AX02, probucol, QT prolonging agents - QT prolonging agents]
[C01BA02, procainamide, QT prolonging agents - QT prolonging agents]
[N01AX10, propofol, QT prolonging agents - QT prolonging agents]
[C01BA01, quinidine, QT prolonging agents - QT prolonging agents]
[J01FA06, roxithromycin, QT prolonging agents - QT prolonging agents]
[C07AA07, sotalol, QT prolonging agents - QT prolonging agents]
